Exchange Traded Concepts Boosts AbbVie Stake by 150%

Asset manager increases holdings in pharmaceutical giant amid strong financial performance.

Mar. 28, 2026 at 8:36am

Got story updates? Submit your updates here. ›

Exchange Traded Concepts LLC, an investment management firm, significantly increased its position in AbbVie Inc. (NYSE: ABBV) during the fourth quarter of 2025. The fund added 62,803 shares, boosting its total stake in the pharmaceutical company by 150.9% to 104,415 shares worth $23.86 million.

Why it matters

AbbVie is a major player in the biopharmaceutical industry, known for its blockbuster drugs like Humira. The company's strong financial results and growth prospects have attracted significant investor interest, as evidenced by this sizable increase in holdings by Exchange Traded Concepts.

The details

According to a 13F filing with the Securities and Exchange Commission, Exchange Traded Concepts lifted its position in AbbVie shares during the fourth quarter of 2025. The fund now owns 104,415 shares of the company's stock, up from 41,612 shares held at the end of the previous quarter.

  • Exchange Traded Concepts increased its AbbVie holdings in the fourth quarter of 2025.
  • The fund's 13F filing with the SEC detailing the position change was made public on March 28, 2026.

The players

Exchange Traded Concepts LLC

An investment management firm that significantly increased its stake in pharmaceutical company AbbVie.

AbbVie Inc.

A global biopharmaceutical company known for blockbuster drugs like Humira.

Got photos? Submit your photos here. ›

The takeaway

The sizable increase in Exchange Traded Concepts' AbbVie holdings reflects the pharmaceutical firm's strong financial performance and growth potential, which continue to attract significant investor interest in the stock.